Difficulty: Medium
Average Score: 67%
Practice
Therapeutic indications of dihydroergotamine include:
Correct answer
C
Rationale
In the context of pharmacology across the lifespan, understanding the therapeutic indications of dihydroergotamine is crucial for healthcare professionals. The correct answer is C) Migraine. Dihydroergotamine is a medication commonly used to treat acute migraine attacks. It works by constricting blood vessels in the brain, which helps to relieve the throbbing pain and other symptoms associated with migraines.
Option A) Hypertension is incorrect because dihydroergotamine can actually increase blood pressure and is not indicated for the treatment of hypertension. Option B) Pheochromocytoma is incorrect as dihydroergotamine can worsen hypertension in patients with this condition due to its vasoconstrictive effects. Option D) RaynaudÔÇÖs phenomenon is incorrect because dihydroergotamine can exacerbate this condition by further constricting blood vessels.
Educationally, understanding the specific therapeutic indications and contraindications of dihydroergotamine is essential for safe and effective clinical practice. Healthcare providers need to be aware of when to appropriately prescribe dihydroergotamine, such as in the case of migraines, and when to avoid its use, such as in patients with hypertension or RaynaudÔÇÖs phenomenon. This knowledge ensures optimal patient outcomes and minimizes potential adverse effects.
Option A) Hypertension is incorrect because dihydroergotamine can actually increase blood pressure and is not indicated for the treatment of hypertension. Option B) Pheochromocytoma is incorrect as dihydroergotamine can worsen hypertension in patients with this condition due to its vasoconstrictive effects. Option D) RaynaudÔÇÖs phenomenon is incorrect because dihydroergotamine can exacerbate this condition by further constricting blood vessels.
Educationally, understanding the specific therapeutic indications and contraindications of dihydroergotamine is essential for safe and effective clinical practice. Healthcare providers need to be aware of when to appropriately prescribe dihydroergotamine, such as in the case of migraines, and when to avoid its use, such as in patients with hypertension or RaynaudÔÇÖs phenomenon. This knowledge ensures optimal patient outcomes and minimizes potential adverse effects.